Researcher
Jonas Steenbrugge
- Keywords:breast cancer, mouse model, oncoimmunology
- Disciplines:Other agricultural, veterinary and food sciences, Animal biology, Veterinary medicine, Other veterinary sciences, Cell growth and development, Inflammation, Innate immunity, Cancer therapy, Cellular interactions and extracellular matrix, Applied immunology, Analysis of next-generation sequence data, Cancer biology, Adaptive immunology, Histology
Affiliations
- Department of Veterinary and Biosciences (Department)
Member
From1 Oct 2021 → Today - Department of Pharmacology, Toxicology and Biochemistry (Department)
Member
From12 Mar 2015 → 30 Sep 2021
Projects
1 - 1 of 1
- Chitinase 3-like 1 as novel immunotherapeutic target in triple-negative breast cancerFrom1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
Publications
1 - 10 of 20
- Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer : proof-of-principle(2023)
Authors: Jonas Steenbrugge, Glenn Pauwelyn, Kristel Demeyere, Nausikaa Devriendt, Hilde De Rooster, Niek Sanders, Jan H. Spaas, Evelyne Meyer, Sina Naserian
- Priming of the murine mammary gland with Staphylococcus chromogenes IM reduces bacterial growth of Streptococcus uberis : a proof-of-concept study(2023)
Authors: Niels Vander Elst, Julie Bellemans, Jonas Steenbrugge, Chloë Geeroms, Koen Breyne, Sofie Piepers, Bruno Toledo Silva, Fernando Nogueira De Souza, Freddy Haesebrouck, Sarne De Vliegher, et al.
- One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer(2022)
Authors: Jonas Steenbrugge, Julie Bellemans, Niels Vander Elst, Josephine De Vliegher, Timothy Perera, Ward De Spiegelaere, Niek Sanders
- OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer(2021)
Authors: Jonas Steenbrugge, Niek Sanders, Eric Ciamporcero, Timothy Perera
- Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer(2021)
Authors: Jonas Steenbrugge, Niels Vander Elst, Kristel Demeyere, Josephine De Vliegher, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera, Evelyne Meyer
Number of pages: 1 - Unexpected effects of a selective and potent c-MET inhibitor in an immunocompetent intraductal model for triple-negative breast cancer(2021)
Authors: Jonas Steenbrugge, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek Sanders, Wim Van Den Broeck, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera, Evelyne Meyer
Number of pages: 1 - Enterobactin deficiency in a coliform mastitis isolate decreases its fitness in a murine model : a preliminary host-pathogen interaction study(2020)
Authors: Niels Vander Elst, Koen Breyne, Jonas Steenbrugge, Amanda Jane Gibson, David George Emslie Smith, Pierre Germon, Dirk Werling, Evelyne Meyer
- Comparative profiling of metastatic 4T1- vs. non-metastatic Py230-based mammary tumors in an intraductal model for triple-negative breast cancer(2019)
Authors: Jonas Steenbrugge, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek Sanders, Wim Van Den Broeck, Luc Dirix, Steven Van Laere, Evelyne Meyer
- Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models(2019)
Authors: Yves Depetter, Rob De Vreese, Sophie Goethals, Elien Vandoorn, Alien Laevens, Jonas Steenbrugge, Pascal de Tullio, Marc Bracke, Matthias D'hooghe
Pages: 735 - 747 - Transparent reporting of experimental parameters in assays measuring phenotypic steps in metastasis(2018)
Authors: Jonas Steenbrugge, Jan Van Deun, An Hendrix
Pages: 715 - 725